skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 21,594  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Strengthening health systems through surgery
Material Type:
Article
Add to My Research

Strengthening health systems through surgery

The Lancet (British edition), 2024-06, Vol.403 (10442), p.2358-2360 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)01031-6 ;PMID: 38782001

Full text available

2
The scope of the antimicrobial resistance challenge
Material Type:
Article
Add to My Research

The scope of the antimicrobial resistance challenge

The Lancet (British edition), 2024-06, Vol.403 (10442), p.2426-2438 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00876-6 ;PMID: 38797176

Full text available

3
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis
Material Type:
Article
Add to My Research

Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis

The Lancet (British edition), 2024-06, Vol.403 (10442), p.2439-2454 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Published by Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00862-6 ;PMID: 38797180

Full text available

4
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
Material Type:
Article
Add to My Research

Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial

The Lancet (British edition), 2024-06, Vol.403 (10442), p.2395-2404 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00702-5 ;PMID: 38761811

Full text available

5
Systemic lupus erythematosus
Material Type:
Article
Add to My Research

Systemic lupus erythematosus

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2326-2338 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00398-2 ;PMID: 38642569

Full text available

6
Cyberattacks on health care—a growing threat
Material Type:
Article
Add to My Research

Cyberattacks on health care—a growing threat

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2263-2263 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)01074-2 ;PMID: 38796195

Full text available

7
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Material Type:
Article
Add to My Research

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2293-2306 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00184-3 ;PMID: 38705160

Digital Resources/Online E-Resources

8
Why not eliminate HTLV-1 while eliminating HIV-1?
Material Type:
Article
Add to My Research

Why not eliminate HTLV-1 while eliminating HIV-1?

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2288-2289 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00295-2 ;PMID: 38796201

Full text available

9
Centring equity in the response to chronic suppurative otitis media
Material Type:
Article
Add to My Research

Centring equity in the response to chronic suppurative otitis media

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2269-2272 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00698-6 ;PMID: 38621396

Full text available

10
Chronic suppurative otitis media
Material Type:
Article
Add to My Research

Chronic suppurative otitis media

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2339-2348 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00259-9 ;PMID: 38621397

Full text available

11
Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa – Authors' reply
Material Type:
Article
Add to My Research

Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa – Authors' reply

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2292-2292 [Peer Reviewed Journal]

2024 ;Copyright Elsevier Limited May 25, 2024 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00633-0 ;PMID: 38796207

Full text available

12
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
Material Type:
Article
Add to My Research

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization

The Lancet (British edition), 2024-05, Vol.403 (10441), p.2307-2316 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00850-X ;PMID: 38705159

Full text available

13
Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
Material Type:
Article
Add to My Research

Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2024-05 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00538-5 ;PMID: 38782004

Full text available

14
3 years after the Myanmar military coup—the people are suffering
Material Type:
Article
Add to My Research

3 years after the Myanmar military coup—the people are suffering

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1966-1969 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00584-1 ;PMID: 38555925

Full text available

15
Totality of evidence refutes neoplasm risk with fezolinetant
Material Type:
Article
Add to My Research

Totality of evidence refutes neoplasm risk with fezolinetant

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1987-1988 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00709-8 ;PMID: 38762322

Full text available

16
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2204-2256 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00685-8 ;PMID: 38762325

Full text available

17
Global Burden of Disease Study 2021 estimates: implications for health policy and research
Material Type:
Article
Add to My Research

Global Burden of Disease Study 2021 estimates: implications for health policy and research

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1958-1959 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00812-2 ;PMID: 38642567

Full text available

18
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2133-2161 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00757-8 ;PMID: 38642570

Digital Resources/Online E-Resources

19
Totality of evidence refutes neoplasm risk with fezolinetant – Authors' reply
Material Type:
Article
Add to My Research

Totality of evidence refutes neoplasm risk with fezolinetant – Authors' reply

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1988-1988 [Peer Reviewed Journal]

2024 Elsevier Ltd ;2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00708-6 ;PMID: 38762323

Full text available

20
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Material Type:
Article
Add to My Research

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet (British edition), 2024-05, Vol.403 (10440), p.2100-2132 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2024 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00367-2 ;PMID: 38582094

Digital Resources/Online E-Resources

Results 1 - 20 of 21,594  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1960  (776)
  2. 1960 To 1975  (2,715)
  3. 1976 To 1991  (5,927)
  4. 1992 To 2008  (7,211)
  5. After 2008  (4,972)
  6. More options open sub menu

Resource Type 

  1. Articles  (21,465)
  2. Reviews  (129)
  3. More options open sub menu

Subject 

  1. General & Internal Medicine  (10,575)
  2. Life Sciences & Biomedicine  (10,555)
  3. Science & Technology  (10,555)
  4. Medicine, General & Internal  (10,551)
  5. Humans  (10,167)
  6. Female  (4,986)
  7. Male  (4,005)
  8. Biological And Medical Sciences  (3,951)
  9. Medical Sciences  (3,931)
  10. Internal Medicine  (3,344)
  11. Patients  (2,806)
  12. Adult  (2,756)
  13. Middle Aged  (2,439)
  14. Mortality  (2,238)
  15. Medical Research  (2,071)
  16. Aged  (1,821)
  17. Risk Factors  (1,770)
  18. Clinical Trials  (1,492)
  19. General Aspects  (1,469)
  20. Incidence  (1,345)
  21. More options open sub menu

Language 

  1. English  (21,591)
  2. Japanese  (1,465)
  3. Norwegian  (15)
  4. Russian  (13)
  5. Portuguese  (1)
  6. French  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait